Related references
Note: Only part of the references are listed.Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation
Rasmus Rivinius et al.
CLINICAL RESEARCH IN CARDIOLOGY (2022)
The mechanism of non-blocking inhibition of sodium channels revealed by conformation-selective photolabeling
Matyas C. Foldi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
The bradycardic agent ivabradine decreases conduction velocity in the AV node and in the ventricles in-vivo
Daniel Amstetter et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
An Advanced Automated Patch Clamp Protocol Design to Investigate Drug-Ion Channel Binding Dynamics
Peter Lukacs et al.
FRONTIERS IN PHARMACOLOGY (2021)
Systemic administration of ivabradine, a hyperpolarization-activated cyclic nucleotide-gated channel inhibitor, blocks spontaneous absence seizures
Yasmine Iacone et al.
EPILEPSIA (2021)
Characterization of Compound-Specific, Concentration-Independent Biophysical Properties of Sodium Channel Inhibitor Mechanism of Action Using Automated Patch-Clamp Electrophysiology
Krisztina Pesti et al.
FRONTIERS IN PHARMACOLOGY (2021)
Structure of the Cardiac Sodium Channel
Daohua Jiang et al.
CELL (2020)
Impaired neuronal sodium channels cause intranodal conduction failure and reentrant arrhythmias in human sinoatrial node
Ning Li et al.
NATURE COMMUNICATIONS (2020)
Reduced Na+ current in Purkinje fibers explains cardiac conduction defects and arrhythmias in Duchenne muscular dystrophy
Janine Ebner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Ventricular arrhythmia suppression with ivabradine in a patient with catecholaminergic polymorphic ventricular tachycardia refractory to nadolol, flecainide, and sympathectomy
Utkarsh Kohli et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2020)
Ivabradine as a stabilising anti-arrhythmic agent for multifocal atrial tachycardia
Mitchell I. Cohen et al.
CARDIOLOGY IN THE YOUNG (2020)
Epilepsy-Related Voltage-Gated Sodium Channelopathies: A Review
Luis Felipe Santos Menezes et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Pore-Lipid Interface: Role of Amino-Acid Determinants of Lipophilic Access by Ivabradine to the hERG1 Pore Domain
Laura Perissinotti et al.
MOLECULAR PHARMACOLOGY (2019)
Ivabradine in Post-operative Junctional Ectopic Tachycardia (JET): Breaking New Ground
Mani Ram Krishna et al.
PEDIATRIC CARDIOLOGY (2019)
Ivabradine possesses anticonvulsant and neuroprotective action in mice
Talita Matias Barbosa Cavalcante et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Ivabradine as an Adjunct for Refractory Junctional Ectopic Tachycardia Following Pediatric Cardiac Surgery: A Preliminary Study
Vivek Kumar et al.
WORLD JOURNAL FOR PEDIATRIC AND CONGENITAL HEART SURGERY (2019)
Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia
Guy Vaksmann et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2018)
Ivabradineis an effective antiarrhythmic therapy for congenital junctional ectopic tachycardia-induced cardiomyopathy during infancy: Case studies
Yakup Ergul et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2018)
Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
Peter Lukacs et al.
SCIENTIFIC REPORTS (2018)
Ivabradine use as an antiarrhythmic therapy in congenital junctional ectopic tachycardias
Yakup Ergul et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2018)
Beneficial effects of ivabradine in atrial or ventricular arrhythmias
Kadir Ugur Mert et al.
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY (2018)
Dose-dependent effects of ivabradine on heart rate during maximal efforts in a woman with permanent atrial fibrillation
Chiara Fossati et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Ivabradine for junctional ectopic tachycardia in post congenital heart surgery
Vivek Kumar et al.
INDIAN HEART JOURNAL (2017)
Effect of ivabradine on cardiovascular outcomes in patients with stable angina: meta-analysis of randomized clinical trials
Hayelom Gebrekirstos Mengesha et al.
BMC CARDIOVASCULAR DISORDERS (2017)
The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 Patients
Ibrahim Halil Tanboga et al.
CLINICAL CARDIOLOGY (2016)
Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction
Gerd Heusch et al.
DRUGS (2016)
Adjunctive ivabradine in combination with amiodarone: A novel therapy for pediatric congenital junctional ectopic tachycardia
Jana-Katharina Dieks et al.
HEART RHYTHM (2016)
Ivabradine reduced ventricular rate in patients with non-paroxysmal atrial fibrillation
Wanwarang Wongcharoen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Pleiotropic, heart rate-independent cardioprotection by ivabradine
P. Kleinbongard et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide
Juan Tamargo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Ivabradine for rate control in atrial fibrillation
Jedrzej Kosiuk et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
The genetic basis for inherited forms of sinoatrial dysfunction and atrioventricular node dysfunction
Raffaella Milanesi et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2015)
Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4
James P. Lees-Miller et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
hERG Potassium Channel Blockade by the HCN Channel Inhibitor Bradycardic Agent Ivabradine
Dario Melgari et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Combined Actions of Ivabradine and Ranolazine Reduce Ventricular Rate During Atrial Fibrillation
Richard L. Verrier et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2015)
Mechanism of Modification, by Lidocaine, of Fast and Slow Recovery from Inactivation of Voltage-Gated Na+ Channels
Vaibhavkumar S. Gawali et al.
MOLECULAR PHARMACOLOGY (2015)
Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials
Ruairidh I. R. Martin et al.
HEART (2014)
If inhibition in the atrioventricular node by ivabradine causes rate-dependent slowing of conduction and reduces ventricular rate during atrial fibrillation
Richard L. Verrier et al.
HEART RHYTHM (2014)
Might ivabradine be useful in permanent atrial fibrillation?
Ghassan Moubarak et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Potential New Indication for Ivabradine: Treatment of a Patient with Congenital Junctional Ectopic Tachycardia
Saleh Al-Ghamdi et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2013)
Identification of the Molecular Site of Ivabradine Binding to HCN4 Channels
Annalisa Bucchi et al.
PLOS ONE (2013)
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression
S. Suffredini et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
On the relationship between block of the cardiac Na+ channel and drug-induced prolongation of the QRS complex
A. R. Harmer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Electrophysiological effects of ivabradine in dog and human cardiac preparations: Potential antiarrhythmic actions
Istvan Koncz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Profound bradycardia with lidocaine during anesthesia induction in a silent sick sinus syndrome patient
Kyoung Ok Kim et al.
JOURNAL OF CLINICAL ANESTHESIA (2011)
Molecular architecture of the human specialised atrioventricular conduction axis
I. D. Greener et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Voltage-Gated Ion Channel Dysfunction Precedes Cardiomyopathy Development in the Dystrophic Heart
Xaver Koenig et al.
PLOS ONE (2011)
Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels
Stephan A. Pless et al.
NATURE COMMUNICATIONS (2011)
Ivabradine: a new rate-limiting therapy for coronary artery disease and heart failure
Gordon F. Rushworth et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2011)
Efficacy of Ivabradine, a Selective I-f Inhibitor, in Patients With Chronic Stable Angina Pectoris and Diabetes Mellitus
Jeffrey S. Borer et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Classification of Drugs Based on Properties of Sodium Channel Inhibition: A Comparative Automated Patch-Clamp Study
Nora Lenkey et al.
PLOS ONE (2010)
Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure
Paul Milliez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Lidocaine Protects from Myocardial Damage due to Ischemia and Reperfusion in Mice by Its Antiapoptotic Effects
Dominik J. Kaczmarek et al.
ANESTHESIOLOGY (2009)
Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction
G. Heusch
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Cardiac sodium channel (SCN5A) variants associated with atrial fibrillation
Dawood Darbar et al.
CIRCULATION (2008)
I-f inhibition with ivabradine - Electrophysiological effects and safety
Irina Savelieva et al.
DRUG SAFETY (2008)
Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure
Gaetano M. De Ferrari et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
Genetic Na+ channelopathies and sinus node dysfunction
Ming Lei et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2008)
Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity
C. Thollon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The promiscuous nature of the cardiac sodium current
V. Haufe et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels
A Bucchi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Pharmacological characterisation of sodium channels in sinoatrial node pacemaking in the rat heart
R Létienne et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Chronic heart rate reduction remodels ion channel transcripts in the mouse sinoatrial node but not in the ventricle
AL Leoni et al.
PHYSIOLOGICAL GENOMICS (2005)
Sinus node dysfunction following targeted disruption of the murine cardiac sodium channel gene Scn5a
M Lei et al.
JOURNAL OF PHYSIOLOGY-LONDON (2005)
Requirement of neuronal- and cardiac-type sodium channels for murine sinoatrial node pacemaking
M Lei et al.
JOURNAL OF PHYSIOLOGY-LONDON (2004)
Architectural and functional asymmetry of the His-Purkinje system of the murine heart
L Miquerol et al.
CARDIOVASCULAR RESEARCH (2004)
Heart rate lowering by specific and selective I-f current inhibition with ivabradine - A new therapeutic perspective in cardiovascular disease
D DiFrancesco et al.
DRUGS (2004)
An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node
SKG Maier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Current-dependent block of rabbit sino-atrial node If channels by ivabradine
A Bucchi et al.
JOURNAL OF GENERAL PHYSIOLOGY (2002)
Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a
GA Papadatos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Functional expression of GFP-linked human heart sodium channel (hH1) and subcellular localization of the a subunit in HEK293 cells and dog cardiac myocytes
T Zimmer et al.
JOURNAL OF MEMBRANE BIOLOGY (2002)
Share Paper
